The Size of the Proteins Assays Market in Europe is valued at USD 0.41 Billion in 2019 and estimated to be growing at a CAGR of 10.7%, to reach USD 0.68 Billion by 2024 during the forecast period 2019-2024.
Protein quantification is a vital step of the dairy workflow of protein extraction in biochemistry and molecular biology that includes protein extraction, analysis or labeling. Quantification of proteins is essential for any sample before isolation, while separation and analysis by electrophoresis or chromatography or any other techniques. There are various methods to estimate the concentration of protein like Bradford, Lowry, BCA and UV spectroscopic Protein assays.
Market Drivers:
Primary factors driving the market forward are an increase in government funding and initiatives, rapid technological advancements in protein assay techniques, increasing incidence rate of chronic diseases like cardiovascular, neurological and other infectious diseases, increasing expenditure on pharmaceutical and biological R&D. But, adverse drug reactions of anticonvulsants, stringent regulatory framework, and unapproved bipolar drugs may confine the growth of the market. Rising application of protein content determination in various fields related to pharmacy and biotechnology has stimulated the growth of the market.
This research report on the Europe Proteins Assays Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.
By Product: Reagents, Kits, Instruments
By Type: Dye-Binding, Copper-Ion Based, Test Strip
By Technology: Absorbance, Colorimetric, Fluorescence
By Application: Drug Discovery, Diagnosis
By End User: Academic And Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals, Clinical Laboratories
By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe
The U.K. is leading the market while Germany is in second place. Growth in Pharmaceutical and biotechnological industries, a strong trend of R&D in the life sciences industry, increasing private-public partnership for drug development has helped these regions dominate the market. Germany is expected to grow the fastest due to increasing research funding, growing proteomics and genomics techniques and rising adoption of advanced Proteins Assays techniques. Dye binding proteins assays segment holds the major share in the market based on type, due to increasing usage of dye-binding assays in disease diagnosis. Absorbance-based protein assays held a major share in the market based on technology due to increased sensitivity and accuracy of this technology.
Promising Companies dominating this Europe Proteins Assays Market Profiled in the Report are Abcam PLC., Bio-Rad Laboratories Inc., Biovision Inc., Cell Signaling Technology Inc, GE Healthcare, PerkinElmer Inc., Thermo Fisher Scientific, Geno Technology Inc., Lonza Group, Merck KGaA, Novus Biologicals, LLC.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Reagents
5.1.3 Kits
5.1.4 Instruments and Services
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Type
5.2.1 Introduction
5.2.2 Dye-Binding Assays
5.2.3 Copper-Ion-Based Assays
5.2.4 Test Strip-Based Assays
5.2.5 Other Protein Assays
5.2.6 Y-o-Y Growth Analysis, By Type
5.2.7 Market Attractiveness Analysis, By Type
5.2.8 Market Share Analysis, By Type
5.3 Technology
5.3.1 Introduction
5.3.2 Absorbance-Based Protein Assays
5.3.3 Colorimetric Protein Assays
5.3.4 Fluorescence-Based Protein Assays
5.3.5 Y-o-Y Growth Analysis, By Technology
5.3.6 Market Attractiveness Analysis, By Technology
5.3.7 Market Share Analysis, By Technology
5.4 Application
5.4.1 Introduction
5.4.2 Drug Discovery & Development
5.4.3 Disease Diagnosis
5.4.4 Other Applications
5.4.5 Y-o-Y Growth Analysis, By Application
5.4.6 Market Attractiveness Analysis, By Application
5.4.7 Market Share Analysis, By Application
5.5 End User
5.5.1 Introduction
5.5.2 Academic and Research Institutes
5.5.4 Pharmaceutical & Biotechnology Companies
5.5.4 Hospitals
5.5.5 Clinical Laboratories
5.5.6 Other End Users
5.5.7 Y-o-Y Growth Analysis, By End User
5.5.8 Market Attractiveness Analysis, By End User
5.5.9 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type
6.1.3.4 By Technology
6.1.3.5 By Application
6.1.3.6 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type
6.1.4.4 By Technology
6.1.4.5 By Application
6.1.4.6 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type
6.1.5.4 By Technology
6.1.5.5 By Application
6.1.5.6 By End User
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Abcm PLC
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
Related Reports
